SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Drug safety, crop protection and animal testing alternatives mulled at SOT

Employee safety is a focus for drugmakers and a growing market for the preclinical testing services sector according to Huntingdon Life Sciences.

Biorasi latest CRO to join Medidata's Rave party

Biorasi has become the latest CRO to ink a deal to use Medidata's Rave cloud-based clinical trial management technology.

CRO pricing power remains ‘elusive,’ analyst says

As biotech and mid-sized pharma companies continue to drive growth for CROs (contract research organizations), the expected ramping up of prices due to increased competition has yet to fully materialize, experts say.

PETA joins preclinical CROs at SOT to promote animal testing alternatives

Testing the toxicity of drug candidates in animals is archaic and unreliable according to PETA, which joined preclinical CROs at SOT to put forward alternatives.

Parexel to tap additional pharmacovigilance services with QSI acquisition

Global CRO Parexel has signed a definitive agreement to acquire privately-owned, Chandigarh, India-based Quantum Solutions India, a provider of specialized pharmacovigilance services. 

‘Game changer’: latest GDP rules spell full traceability for APIs

Makers and distributors of APIs (active pharmaceutical ingredients) will have to track their products throughout the supply chain and meet rules on cold chain transport and outsourcing under revised guidance from the European Commission.

Spotlight

Outsourcing market’s recently IPO'd stock prices see early spike

Outsourcing market’s recently IPO'd stock prices see early spike

Between May 2013, when Quintiles went public , and this week, newly public companies’ stocks in the biopharma...

US FDA working to make clinical trials less wasteful

US FDA working to make clinical trials less wasteful

The US FDA is looking to set up master protocols that can continuously run and help cut...

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

In what was largely a pep rally for science, President Obama on Friday unveiled his $215m precision...

Strong USD to hit revenues but strategic CROs may see lower costs

Strong US Dollar to hit revenues but strategic CROs may see lower costs

The strengthening US Dollar will reduce CRO revenues, say analysts, but firms which have global strategic deals...

Biosimulation – the next step in PK modelling embraced by regulators

Biosimulation – the next step in PK modelling embraced by regulators

Computer-based drug modelling is moving from a discovery aid to a clinical tool accepted by regulators, according...